Overview

Project Location: Sri Lanka – Nation’s first Insulin Manufacturing Facility

FabLab’s Role: Full EPC support with process design & equipment selection

Core Expertise: Biologics & fermentation-based API production

Technology Transfer: Seamless integration ensuring global quality benchmarks

Key Objective: Support local healthcare needs with advanced insulin production

Impact: Major step towards pharmaceutical self-reliance in Sri Lanka

Highlight: A regional milestone led by FabLab’s innovative EPC capabilities

 

Service Turnkey
Facility Injectable
Country Srilanka
Area 10,00,000sqft